Aerie Pharma (AERI) PT Lowered to $30 at Cowen as CEO Steps Down

September 21, 2021 11:42 AM EDT
Get Alerts AERI Hot Sheet
Price: $13.16 +2.89%

Rating Summary:
    18 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 19 | New: 48
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cowen analyst Ken Cacciatore lowered the price target on Aerie Pharma (NASDAQ: AERI) to $30.00 (from $50.00) while maintaining an Outperform rating following news CEO Vince Anido will step down.

The analyst commented, "Aerie disclosed that Vince Anido has stepped down from his role as a CEO and Chairman. The company has appointed Benjamin McGraw as interim Executive Chairman, and has commenced a search for a new CEO. We have little insight to offer but as we speculate below we believe it could indicate that the company will now explore a potential sale."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Cowen & Co